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Previous studies have suggested that insulin resis-
tance develops secondary to diminished fat oxida-
tion and resultant accumulation of cytosolic lipid
molecules that impair insulin signaling. Contrary to
this model, the present study used targeted metab-
olomics to find that obesity-related insulin resistance
in skeletal muscle is characterized by excessive
b-oxidation, impaired switching to carbohydrate
substrate during the fasted-to-fed transition, and
coincident depletion of organic acid intermediates
of the tricarboxylic acid cycle. In cultured myotubes,
lipid-induced insulin resistance was prevented by
manipulations that restrict fatty acid uptake into
mitochondria. These results were recapitulated in
mice lacking malonyl-CoA decarboxylase (MCD),
an enzyme that promotes mitochondrial b-oxidation
by relieving malonyl-CoA-mediated inhibition of
carnitine palmitoyltransferase 1. Thus, mcd/ mice
exhibit reduced rates of fat catabolism and resist
diet-induced glucose intolerance despite high intra-
muscular levels of long-chain acyl-CoAs. These find-
ings reveal a strong connection between skeletal
muscle insulin resistance and lipid-induced mito-
chondrial stress.
INTRODUCTION
Insulin resistance, a state in which peripheral tissues are ren-
dered unresponsive to the glucose-lowering, antilipolytic, and
anabolic properties of the hormone, is a hallmark of obesity and
type 2 diabetes. This condition typically develops in association
with weight gain, prolonged physical inactivity, and/or systemic
hyperlipidemia, thereby suggesting that the molecular underpin-
nings of insulin resistance might be driven by lipid surplus.Indeed, research over the past two decades has established
acompelling connectionbetweenorgandysfunction andatypical
storage of neutral lipids in tissues such as liver, heart, pancreas,
and skeletal muscle (Muoio and Newgard, 2006).
The present investigation sought to advance our understand-
ing of lipid-inducedmetabolic decline in skeletalmuscle, a princi-
pal site of insulin-stimulated glucose clearance. Both in vitro and
in vivo, exposure of skeletal muscle to an excessive lipid supply
leads to intramuscular accumulation of fatty acid-derived me-
tabolites and coincident lesions in insulin action (Hulver et al.,
2003; Yu et al., 2002; Chavez et al., 2003). One prominent theory
suggests that muscle insulin resistance arises from impaired
mitochondrial uptake and oxidation of fatty acids (Morino
et al., 2006; Ruderman et al., 1999). This model proposes that
long-chain acyl-CoAs (LC-CoAs) derived from circulating lipids
or intramuscular triacylglycerol (IMTG) are diverted away from
carnitine palmitoyltransferase 1 (CPT1), the mitochondrial
enzyme that catalyzes the first and essential step in b-oxidation
of long-chain fatty acids, and are instead preferentially parti-
tioned toward the synthesis of signaling intermediates such as
diacylglycerol (DAG) and ceramide. Aberrant accumulation of
these and other bioactive lipid molecules is thought to engage
stress-activated serine kinases that interfere with insulin signal
transduction (Holland et al., 2007; Yu et al., 2002).
Recent studies have challenged this theory by showing that
genetic manipulations that increase tissue levels of these lipid
molecules do not necessarily produce insulin resistance (An
et al., 2004; Monetti et al., 2007). Moreover, emergent evidence
from our laboratory suggests that obesity-associated glucose
intolerance might arise from metabolic overload of muscle mito-
chondria (An et al., 2004; Koves et al., 2005a). This hypothesis
was addressed herein using targeted metabolomics to assess
lipid-induced metabolic dysfunction in both animal and cell cul-
ture models. Our results link the development of skeletal muscle
insulin resistance to excessive rather than reduced b-oxidation
and, moreover, suggest that fatty acids must penetrate muscle
mitochondria to exert their insulin-desensitizing actions on this
tissue. These findings suggest that pharmacologic strategies
designed to boost b-oxidation be reconsidered.Cell Metabolism 7, 45–56, January 2008 ª2008 Elsevier Inc. 45
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prandial SerumNonesterified Fatty Acids andAcylcar-
nitines
Serum samples were harvested in the ad lib fed or 24 hr
starved state from rats fed either standard chow (SC) or
high-fat (HF) diet for 12 weeks. Data represent means ±
SEM from 4–5 animals per group. *p < 0.05 relative to HF diet.
(A) Total nonesterified fatty acid (NEFA) levels.
(B) Individual serum NEFA species in the fed state measured
by gas chromatography/mass spectrometry.
(C) Acylcarnitine species in the fed state measured by tandem
mass spectrometry.
by a family of carnitine acyltransferases that reside
in subcellular organelles (primarily mitochondria),
where they catalyze the exchange of CoA for carni-
tine (Ramsay, 2000). Whereas acyl-CoAs cannot
cross the mitochondrial membrane, the acylcarni-
tines do so efficiently. Subsequently, cytosolic
acylcarnitines can be exported into the blood.
The serum acylcarnitine profile therefore provides
an integrated systemic snapshot of in vivo sub-
strate flux through specific steps of b-oxidation
and amino acid catabolism and is commonly
used as a diagnostic tool for detecting inborn errors
in metabolism (Van Hove et al., 1993).
Complete results of the serum acylcarnitine anal-
ysis are provided in Table S1 available online.
Even-chain species ranging in length from C6 to
C22 arise from incomplete b-oxidation of fatty
acids. Odd-chain species such as C3 (propionyl-
carnitine) and C5 (isovalerylcarnitine) are produced
during amino acid catabolism, whereas C4 (butyr-
ylcarnitine) can be derived from both fatty acidsRESULTS
Obesity Is Characterized by Mitochondrial
Lipid Overload
Animals fed a ‘‘western’’ high-fat (HF) diet for 12 weeks exhibited
23% increased body weight compared to standard chow
(SC)-fed controls (633 ± 40 g and 515 ± 70 g in HF-fed versus
SC-fed rats), which was accompanied by early-stage insulin re-
sistance, mild hyperinsulinemia, hyperleptinemia, hypertrigly-
ceridemia, and elevated glucocorticoid levels (An et al., 2004;
Koves et al., 2005a). As expected, total serum nonesterified
free fatty acids (NEFA) were elevated in response to an overnight
fast and prolonged HF feeding; however, in the present study,
the diet-induced increase was apparent only in the postprandial
state (Figure 1A). Using gas chromatography/mass spectrome-
try (GC/MS), we then evaluated diet-induced changes in plasma
levels of specific fatty acid species. Oleate (C18:1), palmitate
(C16:0), linoleate (C18:2), and stearate (C18:0) were the most
elevated fatty acids in HF-fed animals (Figure 1B).
Tandem MS/MS was then used to analyze 36 independent
acylcarnitine species ranging in size from 2 to 22 carbons, repre-
senting byproducts of substrate catabolism. These acylcarnitine
esters are formed from their respective acyl-CoA intermediatesand amino acids. Acetylcarnitine (C2) derives
from acetyl-CoA, the universal degradation product of all meta-
bolic substrates, and is thus the most abundant species in both
tissues and blood. In response to overnight fasting, most lipid-
derived acylcarnitines increased, whereas the amino acid inter-
mediates decreased. Consistent with the fasting-induced rise
in circulating NEFA, this profile implies a metabolic switch favor-
ing higher rates of b-oxidation and diminished degradation of
amino acids. Under fasting conditions, serum acylcarnitines
were similar between the two diet groups. Conversely, serum
samples collected in the fed state revealed higher levels of sev-
eral fatty acid-derived species and reduced levels of C3, C4, and
C5 in HF-fed animals compared to SC-fed animals (Figure 1C).
Skeletal muscle serves as a major reservoir of free carnitine
and is thought to be a principal contributor to the serum acylcar-
nitine pool. We therefore evaluated acylcarnitine levels in the
gastrocnemius, a representative muscle comprised of a mixture
of type I, IIa, and IIb fibers. Consistent with the serum profile, we
observed marked accumulation of fatty acylcarnitine species in
muscles from HF-fed rats. Whereas SC-fed rats lowered most
muscle fatty acylcarnitines during the transition from the fasted
to the fed state, HF-fed animals exhibited little or no change
(Figure 2A). Thus, during fasted conditions, the import of fatty
acids into muscle mitochondria appears to exceed metabolic
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group, suggesting that mitochondria from obese animals are
unable to appropriately adjust fatty acid influx in response to
nutritional status.
In contrast to skeletal muscle, liver acylcarnitines were not
elevated in HF-fed animals compared to SC-fed animals
(Figure S1A). Moreover, in SC-fed rats, long-chain acylcarnitine
levels increased during the fed-to-fasted transition, consistent
with increased CPT1 activity, whereas this response was im-
paired in the HF-fed group. Likewise, fasting-induced upregula-
tion of CPT1a (the liver isoform) was abolished by HF feeding
(Figure S1B). These data are consistent with the notion that liver
fatty acid oxidation begins to fail within 12 weeks of overfeeding.
We subsequently analyzed skeletal muscle and liver acylcarni-
tine levels in 15-month-old rats fed on the HF diet for 1 year,
a model that mimics lifetime overnutrition in middle-aged hu-
mans. Upon prolonged HF diet exposure, fatty acid-derived
acylcarnitines were uniformly and markedly decreased in liver
but remained elevated in skeletal muscle (Figure S2). To deter-
mine whether this metabolite pattern might be common to
more severe forms of insulin resistance, we next evaluated
Zucker diabetic fatty (ZDF) rats, which develop obesity and dia-
betes secondary to hyperphagia and a mutation in the leptin
receptor gene. Similar to in HF-fed animals, muscle acylcarnitineCell MetaFigure 2. Skeletal Muscle Acylcarnitine Profiles Re-
veal Excessive b-Oxidation in Multiple Forms of Insu-
lin Resistance
(A) Acylcarnitine levels in whole gastrocnemius muscles har-
vested in the ad lib fed or 24 hr starved state from rats fed
either SC or HF diet for 12 weeks. Data represent means ±
SEM from 4–5 animals per group.
(B) Acylcarnitine levels in whole gastrocnemius muscles har-
vested in the ad lib fed state from lean or obese Zucker dia-
betic fatty (ZDF) rats. Data represent means ± SEM from 3
animals per group.
Main effects of starvation (p < 0.01), diet (p < 0.01), and geno-
type (p < 0.01) were detected by two-way ANOVA or Student’s
t test, but symbols were excluded for simplicity.
accumulation (Figure 2B) and mRNA levels of sev-
eral b-oxidative genes (Figure S3) were elevated in
obese ZDF animals as compared to their lean
Zucker littermates. Together, these data support
a model in which the development and progression
of insulin resistance correspond with increased mi-
tochondrial fatty acid catabolism in muscle but re-
duced fat oxidation in liver.
To gain further insight into diet-induced changes
in muscle fuel metabolism, we used GC/MS to pro-
file organic intermediates of glycolysis and the TCA
cycle in skeletal muscle. The HF diet reduced levels
of lactate, citrate, malate, and succinate (Figures
3A–3C). In general, concentrations of these organic
acids were less responsive to nutritional status in
HF-fed compared to SC-fed animals, although
the interaction did not reach statistical significance.
We also observed a similar trend of lower organic
acid levels in gastrocnemius muscles from ZDFrats compared to control rats (Figure 3D). Analysis
of these data sets by multivariate analysis of variance (MANOVA)
revealed a main effect (p < 0.05) of diet and genotype when the
TCA cycle intermediates were modeled as a group.
High-Fat Feeding Impairs Mitochondrial Control
Mitochondrial b-oxidative capacity was assessed using two dis-
tinct in vitro preparations. Crude measures of b-oxidation were
initially performed in skeletal muscle homogenates prepared
from red and white quadriceps femoris. As expected, oxidation
rates of [14C]oleate were several-fold higher in mitochondria-en-
riched red skeletal muscle (Figures 4A and 4B). The 12-week HF
diet did not affect complete oxidation of oleate to CO2. Radiola-
bel incorporation into acid-soluble metabolites (ASMs), which
provides an index of incomplete fat catabolism (Koves et al.,
2005a), was elevated after HF feeding as compared to SC feed-
ing. This effect was more pronounced in white compared to red
quadriceps.
Because the homogenate preparation does not account for
differences in mitochondrial content or other nonmitochondrial
enzymatic activities, we also evaluated rates of fatty acid catab-
olism in isolatedmitochondria from the whole gastrocnemius. As
described previously, mitochondria from HF-fed rats compared
to SC-fed rats displayed similar rates of [14C]oleate oxidation to
CO2 but accumulated more radiolabeled intermediates in thebolism 7, 45–56, January 2008 ª2008 Elsevier Inc. 47
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(A–C) Organic acid levels in whole gastrocnemius muscles harvested in the ad lib fed or 24 hr starved state from rats fed either SC or HF diet for 12 weeks. Data
represent means ± SEM from 4–5 animals per group. *p < 0.05 for main diet effect between individual species by two-way ANOVA.
(D) Organic acid levels in whole gastrocnemius muscles harvested in the ad lib fed state from lean Zucker and obese ZDF rats. Data are expressed as percent
decrease in ZDF animals compared to lean control animals. Data represent means ± SEM from 9 animals per group. zp < 0.05 for genotype difference by Stu-
dent’s t test.acid-soluble pool (Koves et al., 2005a). In the present experi-
ments, we sought to simulate the transition between fasting
and feeding by adding pyruvate to the incubation buffer as
a competing glucose-derived carbon source (Figures 4C and
4D). In mitochondria from SC-fed animals, pyruvate caused an
appropriate and robust inhibition of oleate oxidation, consistent
with substrate switching as predicted by the ‘‘glucose-fatty acid
cycle’’ (Randle et al., 1963). By contrast, this switch was nearly
absent in mitochondria harvested from the HF-fed group.
Exposure to Fatty Acids Disrupts Mitochondrial Fuel
Homeostasis in Cultured Myotubes
We next examined the consequences of lipid surplus in cultured
myocytes. Rat L6myotubeswere exposed to 500 mM fatty acids,
using an equimolar ratio of oleate and palmitate, the two most
abundant fatty acids in serum of HF-fed rats (Figure 1). Carnitine
was used as a nutritional tool to manipulate rates of b-oxidation.
Carnitine is synthesized in the liver and sequestered in skeletal
muscle at estimated concentrations of 2–3 mM, whereas carni-
tine stores in cultured myocytes are extremely low (Figure S4).
It is noteworthy that many cell-based studies of insulin resis-
tance have been performed in myocytes exposed to palmitate,
but in the absence of carnitine and other unsaturated fatty acids
(Chavez et al., 2003; Lee et al., 2006). Such conditions represent
a severe departure from in vivo fuel metabolism and are likely to
elicit cytotoxic responses (Rachek et al., 2007). The toxic effects
of palmitate per se have been attributed to its low rate of incor-
48 Cell Metabolism 7, 45–56, January 2008 ª2008 Elsevier Inc.poration into triacylglycerol (TAG), which in turn leads to abnor-
mal accumulation of palmitoyl-CoA, DAG, and/or ceramide. As
proof of this concept, Figure 5 shows changes in TAG content
and glycerol release (a measure of TAG turnover) in L6 myotubes
treated for 24 hr with palmitate compared to oleate with or with-
out carnitine. TAG levels were below detection limits in control
cells grown in standard medium (data not shown) and increased
upon fatty acid exposure (Figure 5A). In the absence of supple-
mental carnitine, b-oxidation is severely restricted (Figure S1);
thus, fatty acids are preferentially partitioned toward alternative
biosynthetic fates. As predicted, TAG biosynthesis was much
lower in cells exposed to palmitate as compared to oleate or
the oleate-palmitate mix (Figures 5A and 5B). This low potential
for TAG biosynthesis was accompanied by increased cell death
as assessed by adenylate kinase leak into the medium
(Figure 5C). Cell viability was partially or fully rescued when the
addition of carnitine or oleate permitted enhanced utilization of
palmitate for b-oxidation or TAG synthesis, respectively.
Exposure of L6 myotubes to high (500 mM) compared to low
(100 mM) levels of fatty acids resulted in a disproportionate in-
crease in the rate of incomplete ([14C]oleate incorporation into
ASMs) relative to complete ([14C]oleate incorporation into CO2)
oxidation of fatty acids (Figure S4). Likewise, fatty acid surplus
caused cultured myocytes to accumulate even-chain acylcarni-
tines of short, medium, and long chain length, whereas odd-
chain species (C3 and C5) decreased (Figure 5D). Palmitoylcar-
nitine (C16) content was 3-fold greater than oleoylcarnitine
Cell Metabolism
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b-Oxidation and Metabolic Inflexibility in Skeletal
Muscle
Muscles were harvested from rats fed either SC or HF diet for
12 weeks. Data represent means ± SEM from 4–5 animals per
group. *p < 0.05 relative to SC diet; zp < 0.05 relative to no
pyruvate condition.
(A) Complete oxidation of 200 mM [1-14C]oleate to CO2 inmus-
cle homogenates prepared from deep (Red Quad) or superfi-
cial (White Quad) quadriceps.
(B) Incomplete oxidation of 200 mM [1-14C]oleate to acid-solu-
ble metabolites (ASM) in muscle homogenates prepared from
deep (Red Quad) or superficial (White Quad) quadriceps.
(C) Complete oxidation of 200 mM [1-14C]oleate to CO2 in
isolated mitochondria from whole gastrocnemius muscle, in-
cubated with or without 2 mM pyruvate.
(D) Incomplete oxidation of 200 mM [1-14C]oleate to ASM in
isolated mitochondria from whole gastrocnemius muscle,
incubated with or without 2 mM pyruvate.(C18:1), suggesting that palmitate is a preferred substrate for
b-oxidation. Taken together with Figure 5C, these data imply
that acylcarnitine accumulation does not compromise cell viabil-
ity. The lipid-induced changes in the acylcarnitine profile were
fully prevented by coadministration of etomoxir, a potent inhibi-
tor of CPT1 (Figure 5D). In sum, these results strongly suggest
that incubating myocytes with a physiological blend of oleate,
palmitate, and carnitine (as opposed to palmitate alone) better
approximates the metabolic conditions observed in insulin-
resistant animals.
Insulin Resistance in L6 Myocytes Requires b-Oxidation
To further examine the connection between incomplete fat oxi-
dation and insulin resistance, L6 myotubes were pretreated for
24 hr with BSA or BSA complexed with 500 mM fatty acids in
the presence or absence of 1 mM carnitine. Subsequently,
[14C]glucose metabolism was measured in cells provided with
standard culture medium lacking exogenous fatty acids and
carnitine. In BSA-treated control cells, insulin increased rates
of glycogen synthesis but elicited only a minor elevation in glu-
cose oxidation (Figures 5E and 5F). Both glucose oxidation
and glycogen synthesis were inhibited 40%–50% by fatty acid
exposure. Fatty acid-induced decrements in glycogen synthesis
were similar under basal and insulin-stimulated conditions, such
that the relative response to insulin (2.3-fold increase) was un-
changed. Notably, the impairments in glucose metabolism
were evident only when the fatty acid pretreatment was accom-
panied by supplemental carnitine.
Insulin signaling was evaluated following 24 hr preincubation
with or without fatty acids and increasing carnitine concentra-
tions. In the absence of fatty acids, acute insulin administration
triggered robust phosphorylation of AKT (Ser473), a downstream
molecule of the insulin signaling pathway that regulates translo-
cation of the insulin-responsive glucose transporter, GLUT4.
When carnitine was absent, exposure to fatty acids caused
only a modest impairment in AKT activation despite elevatedIMTG (Figure 5G). Conversely, resistance to insulin became pro-
gressively more severe when fatty acid treatment was combined
with increasing doses of carnitine. Likewise, addition of etomoxir
protected against the signaling impairment caused by the com-
bination of fatty acid and carnitine (Figure 5H). These treatments
did not affect total AKT abundance (Figure S4).
mcd/ Mice Are Protected from Diet-Induced
Glucose Intolerance
Malonyl-CoA decarboxylase (MCD) degrades the natural CPT1
inhibitor malonyl-CoA and thereby facilitates fatty acid import
intomitochondria. Knockout mice lackingMCD activity therefore
provide a geneticmodel of partial CPT1 inhibition. These animals
were generated as described previously (Dyck et al., 2006) to
examine the role of MCD in heart disease. Neither the mcd+/
heterozygous nor the mcd/ mice displayed an overt pheno-
type (Dyck et al., 2006). As compared with wild-type animals,
hearts frommcd/mice exhibited elevatedmalonyl-CoA levels,
a marked preference for glucose utilization following ischemia,
and improved cardiac function during recovery from ischemia/
reperfusion.
Here, we used a metabolomics approach to evaluate the con-
sequences of eliminating mcd in skeletal muscle. Ablation of
mcd resulted in an 11-fold increase in muscle levels of malonyl-
carnitine (C3-DC) (Figure 6A), which is derived from malonyl-
CoA. In the setting of an SC diet, levels of most other acylcarni-
tine intermediates in muscle were similar between genotypes
(data not shown); however, distinct phenotypes emerged when
animals were challenged with a HF diet to encourage fatty acid
catabolism. Whereas muscles from wild-type mice had predict-
ably high levels of several fatty acylcarnitines, loss of MCD activ-
ity prevented accumulation of most lipid-derived species
(Figure 6B).
Muscle lactate levels were lower and pyruvate content trended
higher in the mcd/ mice compared to wild-type mice
(Figure 6C). Interestingly, gastrocnemius muscles lacking mcd
Cell Metabolism 7, 45–56, January 2008 ª2008 Elsevier Inc. 49
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Mitochondrial Stress and Muscle Insulin ResistanceFigure 5. Fatty Acid Metabolism and Insulin Resistance in L6 Skeletal Myotubes
(A and B) Triacylglycerol (TAG) synthesis and turnover were assessed in L6 myotubes treated for 24 hr with 500 mM oleate, palmitate, or a 1:1 oleate:palmitate
blend with or without 1 mM L-carnitine. Cellular triacylglycerol content (A) and glycerol release into medium (B) were quantified spectrophotometrically. Data
represent means ± SD from two independent experiments performed in duplicate.
(C) Cytotoxicity was assayed by measuring adenylate kinase activity in the medium after 24 hr exposure to 0, 200, or 500 mM oleate (OA), palmitate (PA), or a 1:1
mix of oleate:palmitate (OP). Data are normalized to total adenylate kinase activity per well and represent means ± SD from two independent experiments per-
formed in duplicate. *p < 0.05 relative to BSA control; zp < 0.05 relative to no carnitine condition.
(D) Acylcarnitine accumulation was measured in L6 myotubes treated with 1 mM L-carnitine and 0.5% BSA, alone or complexed with 500 mM oleate:palmitate
(1:1) with or without 100 mM etomoxir. Data are presented as means ± SD from experiments performed in triplicate and are representative of at least two exper-
iments with similar results.
(E and F) L6 myotubes were pretreated for 24 hr with 0.5% BSA alone or complexed with 500 mM 1:1 oleate:palmitate (FA) ± 2 mM L-carnitine, followed by a 2 hr
incubation with [UL-14C]glucose ± 100 nM insulin, to determine rates of glycogen synthesis (E) and glucose oxidation to CO2 (F). Data are presented as means ±
SD from experiments performed in triplicate and are representative of at least two experiments with similar results.
(G and H) L6 myotubes were pretreated for 24 hr with 0.5% BSA alone or complexed with 500 mM 1:1 oleate:palmitate and increasing concentrations of L-car-
nitine (G) or 2 mM carnitine ± 100 mMetomoxir (H), followed by 15 min stimulation ± 100 nM insulin and western blot analysis of phosphorylated AKT2. MemCode
(memc) staining was used to normalize protein transfer. Data are means ± SD from experiments performed in triplicate and are representative of at least three
other experiments with similar results. *p < 0.05 comparing fatty acid exposure to BSA under the respective conditions by Student’s t test.50 Cell Metabolism 7, 45–56, January 2008 ª2008 Elsevier Inc.
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Mitochondrial Stress and Muscle Insulin ResistanceFigure 6. mcd/ Mice Are Protected against Diet-Induced Glucose Intolerance
(A–C) Metabolic profiling was performed on gastrocnemius muscle lysates from wild-type (WT) andmcd/ (KO) mice fed a HF diet for 12 weeks. Tissues were
harvested in the postprandial state and analyzed for malonylcarnitine (A), fatty acylcarnitine species (B), and organic acids (C).
(D and E) Long-chain acyl-CoAs (LC-Acyl-CoA) (D) and TAG content (E) were measured in mice fed either low-fat (LF) or HF diet for 12 weeks.
(F and G) Whole-body glucose tolerance (F) and insulin sensitivity (G) tests were performed in mice fed a HF diet for 12 weeks.
*p < 0.05 versus WT; zp < 0.05 versus animals of same genotype on SC diet.
Data represent means ± SEM from 6 animals per group.maintained higher levels of succinate, fumarate, and a-ketoglu-
tarate in response to the HF diet, suggesting that excessive
b-oxidation directly contributes to the low levels of these inter-
mediates observed in insulin-resistant rodents. Diet-induced
accumulation of LC-CoAs was evident in both wild-type and
mcd/ mice and tended to be amplified in the latter (Fig-
ure 6D). Intramuscular TAG content followed a similar trend
(Figure 6E).
Insulin action was examined by glucose and insulin tolerance
tests. Wild-type and mcd/ mice responded similarly to these
challenges when animals were fed the SC diet (data not shown);
however, the HF regimen revealed striking genotype-specific re-
sponses. As expected, wild-type mice developed diet-induced
insulin resistance, evidenced by elevated fasting blood glucose,
impaired glucose tolerance, reduced insulin responsiveness,
and rebound hyperglycemia following insulin administration (Fig-
ures 6F and 6G; Figure S5). In contrast, mcd/ mice displayed
remarkable protection against these metabolic perturbations.
Thus, enhanced glucose utilization and insulin sensitivity in the
knockout mice occurred in the face of high intramuscular lipid
levels and diminished rates of b-oxidation.
To gain insight into changes in hepatic lipid metabolism,
we profiled liver metabolites (Figure S6). As in skeletal muscle,
levels of malonylcarnitine in liver were elevated in knockoutmice compared to control mice. However, in general, the acyl-
carnitine, organic acid, and LC-CoA profiles revealed only mod-
est metabolic differences between genotypes. Moreover,
plasma ketone levels were similar between groups, indicating
that hepatic b-oxidation was not severely compromised by the
loss of mcd. We used indirect calorimetry to examine whole-
body substrate utilization during the early phases of HF feeding.
In wild-type mice, the HF diet caused a dramatic decrease in the
respiratory exchange ratio (RER) (Figure 7A), indicative of in-
creased fat oxidation. Similar to our experiments in rats, the
HF regimen abolished the robust fluctuations in substrate selec-
tion apparent in control mice during transitions between light and
dark cycles. These changes were evident within 2 weeks after
initiating the diet and preceded insulin resistance as assessed
by an insulin tolerance test (data not shown). Compared to their
wild-type counterparts,mcd/mice fed the HF diet maintained
a higher RER, reflecting elevated glucose oxidation, but only dur-
ing the dark/active cycle, when systemic substrate use is more
heavily influenced by skeletal muscle (Figure 7B). In the aggre-
gate, ablation of mcd appears to confer partial inhibition of
CPT1 that manifests selectively in skeletal muscle as compared
to liver. Although these findings do not preclude the possibility
that mcd/ mice have enhanced hepatic insulin sensitivity,
the weight of the evidence suggests that changes in skeletalCell Metabolism 7, 45–56, January 2008 ª2008 Elsevier Inc. 51
Cell Metabolism
Mitochondrial Stress and Muscle Insulin Resistancemuscle fatty acid oxidation play a dominant role in conferring
their antidiabetic phenotype.
DISCUSSION
In this report, we show that obesity, diabetes, andHF feeding are
accompanied by increased rather than decreased rates of
b-oxidation in skeletal muscle and that, moreover, nutritional,
pharmacologic, or genetic maneuvers that suppress mitochon-
drial fatty acid import protect against lipid-induced insulin resis-
tance. The high rates of fatty acid catabolism in insulin-resistant
muscles were attributed principally to ‘‘incomplete’’ fat oxida-
tion, in which a large proportion of fatty acids entering the
mitochondria are only partially degraded. Obesity-induced
perturbations in mitochondrial fuel metabolism were further
characterized by impaired switching to carbohydrate substrate
and moderate depletion of several TCA cycle intermediates.
Taken together, our results suggest that dietary fat is less dam-
aging to skeletal muscle metabolic function under conditions of
constrained b-oxidation.
Reciprocal regulation of fat oxidation and glucose disposal
was originally described as the ‘‘glucose-fatty acid cycle’’ (Ran-
dle et al., 1963). Randle (1998) postulated that provision of lipid
52 Cell Metabolism 7, 45–56, January 2008 ª2008 Elsevier Inc.Figure 7. Whole-Body Substrate Oxidation in Wild-
Type and mcd/ Mice
Indirect calorimetry was performed using an eight-chamber
Oxymax system (Columbus Instruments). Mice were acclima-
tized to the system prior to measurement. Respiratory ex-
change ratio (RER) was calculated as VCO2/ VO2. Data repre-
sent means ± SEM from 6–11 animals per group.
(A) Wild-type mice were fed either a 10% fat (LF) or 60% fat
(HF) diet for 2 weeks prior to whole-body metabolic assess-
ments. Measurements were recorded every 40 min.
(B) mcd/ (KO) and wild-type (WT) littermates were fed a HF
diet for 3 weeks prior to whole-body metabolic assessments.
Measurements were recorded every 11 min; data points
shown represent the average of each 55 min interval. Data
were analyzed by Student’s t test. Mean RER during the
dark cycle was greater in KO versus WT mice (p < 0.01).
fuel promotes b-oxidation and suppresses glycoly-
sis and pyruvate oxidation due to inhibition of hexo-
kinase, phosphofructokinase, and pyruvate dehy-
drogenase. More recently, the role of this
mechanism in driving insulin resistance has been
discounted based on magnetic resonance spec-
troscopy (MRS) studies showing that concentra-
tions of glucose and glucose-6-phosphate (the
product of hexokinase) are decreased in skeletal
muscle of human diabetic subjects compared to
control subjects during a hyperinsulinemic-eugly-
cemic clamp (Cline et al., 1994, 1997) and in re-
sponse to prolonged lipid infusion (Dresner et al.,
1999). These reports argue against the notion that
reduced flux through the hexokinase reaction re-
stricts glucose uptake in circumstances of insulinresistance and instead point toward a defect in
insulin-stimulated glucose transport as the limiting factor. In-
deed, numerous studies have shown that HF feeding and/or lipid
exposure impair insulin signaling to GLUT4. However, lipid-me-
diated opposition of GLUT4 translocation could emanate from
a mitochondria-derived signal, as suggested by the current
study. Additionally, the foregoing MRS experiments did not as-
sess changes in pyruvate dehydrogenase activity, which has
been shown to be more potently inhibited by fatty acids than
the glycolytic enzyme phosphofructokinase.
Insulin-stimulated GLUT4 translocation requires a cascade of
protein phosphorylations that commence with autophosphoryla-
tion of the insulin receptor (IR) tyrosine kinase followed by
tyrosine phosphorylation of its immediate substrate, insulin re-
ceptor substrate 1 (IRS-1). Both IR and IRS-1 are negatively reg-
ulated by serine phosphorylation, which opposes phosphoryla-
tion on tyrosine residues and thus impedes activation of
downstream targets, including AKT and GLUT4 (Zick, 2004).
Constitutive serine phosphorylation of IR and IRS has become
increasingly recognized as a major molecular cause of insulin re-
sistance (Morino et al., 2006); however, the precise biochemical
events that provoke this condition remain unresolved. Strong ev-
idence implicates a role for factors such as inflammation and en-
doplasmic reticulum (ER) stress (Cai et al., 2005; Ozcan et al.,
2004). Additionally, much attention has focused on local
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DAG and LC-CoAs, which are attractive candidates because
they have been shown to act as ligands for several stress-re-
sponsive serine kinases in vitro. Thus, increased levels of LC-
CoAs and/or DAG might activate PKC and/or other kinases
that serine phosphorylate IRS-1. In this model, diminished mito-
chondrial uptake and catabolism of fatty acids has been postu-
lated as a primary metabolic insult that forces accumulation of
IMTG and other lipid species (Morino et al., 2006; Zick, 2004;
Yu et al., 2002).
On the other hand, our findings fit with a growing body of
evidence that disassociates muscle insulin resistance from glyc-
erolipid and/or LC-CoA content. For example, muscles from
exercise-trained subjects are highly insulin sensitive despite
IMTG levels that are similar or even higher than those found in
association with obesity and diabetes (Goodpaster and Kelley,
2002). Furthermore, exercise intervention in type 2 diabetic
patients and obese Zucker rats has been shown to improve insu-
lin action inmuscle without a corresponding decrease in LC-CoA
and DAG levels (Bruce et al., 2004; Thyfault et al., 2007). Simi-
larly, a previous study of ours found that insulin-mediated phos-
phorylation of AKT and GSK-3 in muscle of HF-fed rats was re-
stored by a genetic maneuver that tended to increase IMTG
and LC-CoA levels (An et al., 2004). Improved insulin signaling
corresponded with a sharp decrease in muscle levels of b-OH-
butyrylcarnitine, a mitochondria-derived ketone metabolite (An
et al., 2004). Likewise, a 2-week exercise intervention in mice
fed a chronic HF diet lowered muscle acylcarnitine levels in
association with increased TCA cycle activity and complete
reversal of glucose intolerance (Koves et al., 2005a). Taken to-
gether with the current report, these findings cast light on the mi-
tochondrion as a principal target of lipid stress.
The idea that insulin resistance might stem from excessive
b-oxidation agrees with numerous reports showing that lipid ex-
posure, HF diet, and/or obesity increase expression of several
b-oxidative and glucose-sparing enzymes that are targeted by
the PPAR family of lipid-activated transcription factors (Gilde
and Van Bilsen, 2003; Yechoor et al., 2002). Interestingly, activa-
tion of b-oxidative genes is not necessarily coordinated with
increased expression of downstream metabolic pathways such
as the TCA cycle and the electron transport chain. On the con-
trary, HF feeding and obesity result in decreased expression of
PGC-1a, a transcriptional coactivator that functions as a master
regulator of mitochondrial biogenesis and function (Koves et al.,
2005a; Sparks et al., 2005; Mootha et al., 2003). Herein, overnu-
trition and/or insulin resistance lowered muscle levels of several
TCA cycle intermediates, whereas ablation of mcd in knockout
mice prevented this depletion. Thus, sustained elevations in
b-oxidation and/or impaired glucose metabolism appear to re-
duce the TCA cycle intermediate pool. Although the functional
relevance of this finding is as yet unknown, the data are congru-
ent with previous transcriptomic analyses (Koves et al., 2005a;
Sparks et al., 2005; Yechoor et al., 2002) and might reflect com-
promised mitochondrial status.
Consistent with our results, other genetic mouse models
have likewise revealed a negative relationship between muscle
b-oxidation and insulin action (Finck et al., 2005; Ibrahimi et al.,
1999). For instance, muscle-specific overexpression of PPARa
in transgenic mice causes both local and systemic glucoseintolerance, in association withmarked induction of several lipid-
oxidative genes (Finck et al., 2005). The diabetic phenotype of
these animals is reversed by pharmacologic inhibition of CPT1.
Conversely, PPARa null mice have diminished b-oxidative activ-
ity and resist lipid-induced diabetes (Tordjman et al., 2001;
Guerre-Millo et al., 2001). Conflicting evidence from human stud-
ies has shown both increased and decreased fat oxidation in as-
sociation with obesity. Notably, however, most previous studies
have been performed in the fasted state and have not assessed
incomplete b-oxidation. Our studies show that unchanged rates
of complete fat oxidation can be accompanied by high rates of
incomplete b-oxidation. Additionally, we found that obesity-
associated increases in fatty acid catabolism are most apparent
in the postprandial state; this is not surprising given that normal
physiological fluctuations in substrate supply dictate high rates
of b-oxidation during periods of food withdrawal. In other words,
the pathophysiological shift in muscle fuel selection appears to
occur primarily in the fed or semi-fed state. These observations
are reminiscent of previous reports showing that muscles from
obese and/or diabetic subjects lose their capacity to switch
between glucose and lipid substrates (Kelley et al., 1999). Our
results now show that HF feeding causes a form of ‘‘metabolic
inflexibility’’ that not only occurs early in the pathogenesis of dis-
ease but also is detectable in isolated mitochondria.
Importantly, the present study also provides evidence that the
development and progression of insulin resistance involve a dis-
tinct set of metabolic derangements in skeletal muscle as com-
pared to that in liver. Accordingly, the molecular mechanisms
that connect lipid surplus to insulin resistance are likely to exhibit
tissue specificity. In fact, the strongest evidence in favor of
mechanisms involving LC-CoAs, DAG, ER stress, and/or inflam-
mation comes from genetic models and pharmacological inter-
ventions that modulate hepatic lipid metabolism (Nagle et al.,
2007; Savage et al., 2006; An et al., 2004; Dobbins et al., 2001;
Cai et al., 2005; Ozcan et al., 2004). Relevant to the present
study, knockout mice lacking acetyl-CoA carboxylase 2 have
decreased tissue levels of malonyl-CoA and resist diet-induced
obesity and diabetes (Abu-Elheiga et al., 2003), seemingly in
conflict with our results. However, these mice exhibit only minor
adjustments in muscle lipid metabolism but profound changes in
liver lipid metabolism, as evidenced by marked increases in
hepatic b-oxidation and ketogenesis and protection against he-
patic steatosis. Thus, in this as in other similar studies (An et al.,
2004; Nagle et al., 2007), the liver appears to serve as a catabolic
sink that protects against systemic hyperlipidemia.
In contrast to skeletal muscle, the liver harbors robust capacity
to repackage and export fatty acids, not only in the form of very
low-density lipoprotein (VLDL)-TAG but also as ketones, which
are generated by liver mitochondria when reducing potential is
high. Conversely, anabolic pathways such as lipogenesis, gluco-
neogenesis, glycerolipid synthesis, and ketogenesis are rela-
tively inactive in muscle. We therefore suggest that muscle mito-
chondria are particularly vulnerable to energy overload and, as
such, serve as the principal lipid sensors of this tissue. This par-
adigm fits with emerging data linking diabetes to muscle mito-
chondrial dysfunction (Morino et al., 2006) and evidence that
exercise-induced reversal of insulin resistance correlates with
improved mitochondrial performance (Koves et al., 2005a; Men-
shikova et al., 2005).
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rived signal that couples incomplete b-oxidation to insulin resis-
tance. Perhaps specific acylcarnitine esters function as signaling
molecules and/or participate in processes related to protein
acetylation/acylation. In support of this possibility, a recent pro-
teomics report identified several mitochondrial proteins that ap-
pear to be regulated by nutrient-induced changes in acetylation
state (Kim et al., 2006). We emphasize, however, that the acyl-
carnitines per se may not play a direct role in mediating insulin
resistance. In the context of inborn mitochondrial diseases, acyl-
carnitine production has been viewed as a detoxifying system
that permits mitochondrial efflux of excess acyl groups (Ramsay,
2000). Thus, muscle accumulation of these intermediates could
reflect a failed attempt to alleviate reductive and/or oxidative
stress caused by mitochondrial overload (Andreyev et al.,
2005). Notably, reactive oxygen species are known to activate
several of the serine kinases that target IRS-1 (Bloch-Damti
and Bashan, 2005), and recent reports have implicated both ox-
idative and reductive stress as potential diabetogenic culprits
(Houstis et al., 2006; Parikh et al., 2007). These are attractive
scenarios that could explain insulin resistance provoked by over-
supply of any metabolic substrate.
In summary, our report links skeletal muscle insulin resistance
to lipid-induced mitochondrial stress. We propose that HF feed-
ing results in excessive b-oxidation, due to both PPAR-mediated
transcriptional remodeling and increased supply of lipid sub-
strate (Figure S7). In the absence of work (i.e., physical activity),
the TCA cycle not only remains inactivated at a transcriptional
level but is constrained by redox pressure and depletion of sup-
porting intermediates. This imbalanced environment appears
to exacerbate incomplete b-oxidation and encourage intra-
mitochondrial accumulation of acyl-CoAs, their respective acyl-
carnitines, and perhaps other as yet unidentifiedmetabolites that
could contribute to mitochondrial failure. These findings suggest
that drugs designed to enhance CPT1 activity and/or fat oxida-
tion might alleviate metabolic derangements in liver but exacer-
bate those in muscle.
EXPERIMENTAL PROCEDURES
Animal Studies
All animal studies were approved by the Duke University Institutional Animal
Care and Use Committee or the University of Alberta Animal Policy and
Welfare Committee. Male Wistar rats (300 g; Harlan) were housed in a temper-
ature-controlled environment with a 12:12 hr light/dark cycle and provided ad
libitum access to standard chow (SC) (7001; Harlan Teklad) or a 45% high-fat
(HF) diet (D12451; Research Diets) and water. Male ZDF and lean littermate
rats were purchased from Charles River Laboratories. Tissues were harvested
at 12 weeks of age, after the onset of frank diabetes and hyperlipidemia as
assessed by fasting blood levels of glucose, insulin, triglycerides, and NEFA.
On the day of experiments, food was removed either 4 hr (fed) or 24 hr (fasted)
before anesthesia was administered.mcd/mice (Dyck et al., 2006) and wild-
type littermates were fed either a low-fat (10%) or high-fat (60%) diet (D12492;
Research Diets) for 12 weeks. Glucose and insulin tolerance tests were per-
formed 6 hr after food withdrawal using glucose and insulin doses of 2 g/kg
and 0.3 U/kg, respectively.
Plasma Measures
EDTAplasmawas collected after feeding, after overnight fast, and at the timeof
sacrifice and was analyzed for triacylglycerides (#337-B; Sigma), NEFA (NEFA
C kit; Wako Chemicals), insulin (EZRMI-13K; Millipore), leptin (XL85-K; Milli-
pore), and corticosteroids (80100; Diagnostic Systems Laboratories, Inc.).
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Mass spectrometry-based metabolic profiling was performed as described
previously (An et al., 2004; Haqq et al., 2005). Further details are provided in
Supplemental Experimental Procedures.
Muscle Homogenate and Mitochondrial Oxidation
Deep (red) quadriceps, superficial (white) quadriceps, and gastrocnemius
muscles were excised from anesthetized rats and placed in ice-cold modified
Chappell-Perry buffer. Muscle homogenates were prepared from 100 mg
quadriceps samples as described previously (Kim et al., 2002). One gastrocne-
miusmuscle was immediately flash frozen for metabolic profiling, and the con-
tralateral muscle was used formitochondrial isolations as described previously
(Koves et al., 2005b); subsarcolemmal and intermyofibrillar pellets were
combined. Oxidation studies were performed using 0.2 mM [1-14C]oleate in
the absence or presence of 2 mM sodium pyruvate using methods described
in Kim et al. (2002). Reactions were terminated by adding 100 ml 70%
perchloric acid, and 14CO2 was trapped in 200 ml of 1 N NaOH.
14CO2 and
14C-labeled acid-soluble metabolites were assessed by liquid scintillation
counting in Uniscint BD (National Diagnostics).
Cultured Myocytes
L6 myoblasts (ATCC) were grown in DMEM with 10% FBS and induced to dif-
ferentiate by switching to DMEM containing 2% horse serum as described
previously (Muoio et al., 2002). Mature myotubes were treated for 24 hr with
vehicle (0.5% BSA) and/or fatty acids and 0–2.0 mM L-carnitine and then
harvested for assessment of triacylglycerides (GPO-Trinder kit; Sigma) and
protein (BCA assay kit; Pierce) and metabolic profiling. For signaling studies,
L6 cells were harvested 10 min after addition of 100 nM insulin. Lysates
were immediately homogenized in loading buffer consisting of 20 mM Tris-
HCl (ph 7.5), 20% glycerol, 0.02% bromophenol blue, 5% b-mercaptoethanol,
and 4%SDS supplemented with phosphatase and protease inhibitor cocktails
(Sigma-Aldrich). Thirty micrograms of total cell protein was separated on 10%
Criterion gel (Bio-Rad) and transferred to nitrocellulose before blocking and
probing using antibodies against phospho-Akt (Ser473) (1:1,000; Cell Signal-
ing Technology), total Akt (1:1,000; Cell Signaling Technology), or b-tubulin
(1:20,000; Sigma). MemCode stain (Pierce) was used to normalize protein
transfer. Proteins were visualized using horseradish peroxidase-conjugated
immunoglobulin G antibodies and an ECL Plus chemiluminescence detection
kit and quantified using ImageQuant Software (Amersham Biosciences).
Statistics
Data were analyzed by two-tailed Student’s t test or two-way ANOVA when
appropriate using JMP software version 6 (SAS Institute Inc.). ANOVAwas per-
formed on data at a minimum p < 0.05 threshold, and Tukey’s HSD post hoc
test was performed to evaluate differences between treatment groups. Multi-
variate fitting to examine the effect of diet or genotype on organic acids and
acylcarnitines was performed by MANOVA using identity as the response
design.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, one table, and seven figures and can be found with this
article online at http://www.cellmetabolism.org/cgi/content/full/7/1/45/DC1/.
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